Biological and clinical insights from a randomised phase II study of an anti-oncostatin M monoclonal antibody in systemic sclerosis.
Christopher P DentonFrancesco Del GaldoDinesh KhannaMadelon C VonkLorinda ChungSindhu R JohnsonJohn VargaDaniel E FurstJane TempleChiara ZecchinEszter CsomorAmy LeeNicolas WisniackiShaun M FlintJuliet ReidPublished in: Rheumatology (Oxford, England) (2022)
ClinicalTrials.gov registration number: NCT03041025, EudraCT registration number: 2016-003417-95.